Way back in 1994, Apple beat Canon and Nikon to release the first reasonably priced digital camera, the QuickTake 100. Using ...

Enter Gemini, which has the native ability to watch and summarize YouTube videos. If you didn’t already know, you can ask ...

Build your first fully functional, Java-based AI agent using familiar Spring conventions and built-in tools from Spring AI.

What a weekend for Kazuma Okamoto, the Japanese star who is taking over Toronto. Okamoto launched his first Major League home ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

Luke Lindberg, USDA's undersecretary for trade and foreign agricultural affairs. (USDA photo) Luke Lindberg, USDA’s undersecretary for trade and foreign agricultural affairs, is the leading contender ...

Running is one of the best investments you can make in yourself as you get older—and it’s never too late to start (or start again). Our new program, How to Run Strong at 50+, is designed to help you ...

The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability. The WinterCG community group was recently ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Much is being said about the wonders of artificial intelligence (AI) and how it is the new frontier. And while it provides amazing possibilities in fields like medicine, academics are debating its ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.